A.M. van Tubergen

Capelusnik, D., Gardiner, P., Boonen, A., Nikiphorou, E., van der Heijde, D., Landewe, R., van Tubergen, A., & Ramiro, S. (2026). Corrigendum to “Development and validation analysis of a corrected axial spondyloarthritis metrology index (CASMI)” [Seminars in Arthritis and Rheumatism 78 (2026) 152981]. Seminars in Arthritis and Rheumatism, 79, Article 153002. https://doi.org/10.1016/j.semarthrit.2026.153002

Smits, M. L., Webers, C., & van Tubergen, A. (2026). Evidence-based follow-up in axial spondyloarthritis: how much is (not) enough? Current Opinion in Rheumatology, 38(4), 232-237. https://doi.org/10.1097/BOR.0000000000001158

Renet, E., Smits, M. L., van Tubergen, A., Vonkeman, H. E., & Webers, C. (2026). Corrigendum to “The association between residual disease and the risk of future disease flares in axial spondyloarthritis: A longitudinal study (vol. 78, 152980, 2026). Seminars in Arthritis and Rheumatism, 78, Article 152991. https://doi.org/10.1016/j.semarthrit.2026.152991

van Wissen, M. A. T., van Weely, S. F. E., van den Ende, C. H. M., Vliet Vlieland, T. P. M., Teuwen, M. M. H., Peter, W. F., Mahler, E. A. M., van Schaardenburg, D., van Gaalen, F., Spoorenberg, J. P. L., van Tubergen, A. M., Gademan, M. G. J., & van den Hout, W. B. (2026). Cost-utility of long-term exercise therapy in people with axial spondyloarthritis and severe functional limitations: a randomized, controlled trial. Rheumatology International, 46(6), Article 134. https://doi.org/10.1007/s00296-026-06160-x

Capelusnik, D., Gardiner, P., Bonnen, A., Nikiphorou, E., van der Heijde, D., Landewe, R., van Tubergen, A., & Ramiro, S. (2026). Development and validation analysis of a corrected axial spondyloarthritis metrology index (CASMI). Seminars in Arthritis and Rheumatism, 78, Article 152981. https://doi.org/10.1016/j.semarthrit.2026.152981

Zegers, F. D., Qin, L., Selani, D., Gomon, G., Maarseveen, T., Glas, K., van Tubergen, A., Ruiterman, Y. G., Reinders, M., Van den Akker, E., de Jong, C. B., Klareskog, L., Axnas, B., Bos, R., le Cessie, S., & Knevel, R. (2026). Attrition and representativeness in development and validation of online symptom checkers-a case study on the Rheumatic? Questionnaire. Frontiers in artificial intelligence, 9, Article 1815241. https://doi.org/10.3389/frai.2026.1815241

Renet, E., Smits, M. L., van Tubergen, A., Vonkeman, H. E., & Webers, C. (2026). The association between residual disease and the risk of future disease flares in axial spondyloarthritis: A longitudinal study. Seminars in Arthritis and Rheumatism, 78, Article 152980. https://doi.org/10.1016/j.semarthrit.2026.152980

Carbo, M., Kampman, A., Paap, D., Wink, F., Webers, C., Vonkeman, H., van Tubergen, A., Arends, S., & Spoorenberg, A. (2026). Almost half of the patients with axial spondyloarthritis reporting an acceptable symptom state have high disease activity; data from two standard-of-care cohorts. Seminars in Arthritis and Rheumatism, 77, Article 152903. https://doi.org/10.1016/j.semarthrit.2025.152903

van Essen, M., Capelusnik, D., van der Heijde, D., Landewé, R. B. M., van Lankveld, W., van Tubergen, A., Ramiro, S., & Boonen, A. (2026). Coping with rheumatic stressors in long-standing axial spondyloarthritis: association with patient and disease characteristics. Rheumatology, 65(4), Article keag140. https://doi.org/10.1093/rheumatology/keag140

Smits, M. L., Renet, E., Vonkeman, H. E., Webers, C., & van Tubergen, A. (2026). Predictive Value of Severe Symptoms for Residual Disease After Transitioning From High to Low Disease Activity in Axial Spondyloarthritis: A Longitudinal Study. Journal of Rheumatology, 53(4), 386-394. https://doi.org/10.3899/jrheum.2025-0421